SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001174947-14-000222
Filing Date
2014-04-30
Accepted
2014-04-30 09:24:33
Documents
13
Period of Report
2014-06-03
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEF14A b375325_def14a.htm DEF 14A 1054311
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_sareptaside-pms.jpg GRAPHIC 11487
4 GRAPHIC sig_christopher-garabedian.jpg GRAPHIC 4494
5 GRAPHIC sig_davidt-howton.jpg GRAPHIC 4816
6 GRAPHIC spacer.gif GRAPHIC 43
7 GRAPHIC b375325_chrt-bar1.jpg GRAPHIC 25270
8 GRAPHIC b375325_chrt-bar2.jpg GRAPHIC 26419
9 GRAPHIC b375325_chrt-pie.jpg GRAPHIC 22047
10 GRAPHIC b375325_chrt-bar3.jpg GRAPHIC 37502
11 GRAPHIC b375325_chrt-bar4.jpg GRAPHIC 40704
12 GRAPHIC b375325_pc1.jpg GRAPHIC 235382
13 GRAPHIC b375325_pc2.jpg GRAPHIC 190709
  Complete submission text file 0001174947-14-000222.txt   1882667
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 14796155
SIC: 2834 Pharmaceutical Preparations